只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-15 2026-07-17 | HTFL Heartflow, Inc. | Rogers Campbell Officer · Chief Medical Officer | 卖出（S） | 9,219 | US$25.72 | US$237,112.68 | 88,731 | SEC |
| 2026-07-10 2026-07-13 | HTFL Heartflow, Inc. | Farquhar John C.M. Director,Officer · Chief Executive Officer | 卖出（S） | 22,562 | US$27.75 | US$626,095.50 | 435,373 | SEC |
| 2026-06-24 2026-06-26 | HTFL Heartflow, Inc. | Farquhar John C.M. Director,Officer · Chief Executive Officer | 卖出（S） | 38,900 | US$35.00 | US$136.15万 | 457,935 | SEC |
| 2026-06-10 2026-06-12 | HTFL Heartflow, Inc. | Farquhar John C.M. Director,Officer · Chief Executive Officer | 卖出（S） | 22,562 | US$28.50 | US$643,017.00 | 496,835 | SEC |
| 2026-05-18 2026-05-20 | HTFL Heartflow, Inc. | Rogers Campbell Officer · Chief Medical Officer | 卖出（S） | 9,219 | US$28.34 | US$261,266.46 | 78,731 | SEC |
| 2026-05-11 2026-05-13 | HTFL Heartflow, Inc. | Farquhar John C.M. Director,Officer · Chief Executive Officer | 卖出（S） | 22,562 | US$29.12 | US$657,005.44 | 519,397 | SEC |
| 2026-04-30 2026-04-30 | HTFL Heartflow, Inc. | Bain Capital Life Sciences III General Partner, LLC TenPercentOwner | 卖出（S） | 892,533 | US$29.18 | US$2604.41万 | 8,504,382 | SEC |
| 2026-04-30 2026-04-30 | HTFL Heartflow, Inc. | BCLS Fund III Investments GP, LLC TenPercentOwner | 卖出（S） | 892,533 | US$29.18 | US$2604.41万 | 8,504,382 | SEC |
| 2026-04-30 2026-04-30 | HTFL Heartflow, Inc. | Bain Capital Life Sciences Fund III, L.P. TenPercentOwner | 卖出（S） | 892,533 | US$29.18 | US$2604.41万 | 8,504,382 | SEC |
| 2026-04-30 2026-04-30 | HTFL Heartflow, Inc. | Bain Capital Life Sciences Investors, LLC TenPercentOwner | 卖出（S） | 892,533 | US$29.18 | US$2604.41万 | 8,504,382 | SEC |
| 2026-04-30 2026-04-30 | HTFL Heartflow, Inc. | BCLS Fund III Investments, LP TenPercentOwner | 卖出（S） | 892,533 | US$29.18 | US$2604.41万 | 8,504,382 | SEC |
| 2026-04-30 2026-04-30 | HTFL Heartflow, Inc. | Bain Capital Life Sciences III General Partner, LLC TenPercentOwner | 卖出（S） | 56,224 | US$30.05 | US$168.95万 | 8,448,158 | SEC |
| 2026-04-30 2026-04-30 | HTFL Heartflow, Inc. | BCLS Fund III Investments GP, LLC TenPercentOwner | 卖出（S） | 56,224 | US$30.05 | US$168.95万 | 8,448,158 | SEC |
| 2026-04-30 2026-04-30 | HTFL Heartflow, Inc. | Bain Capital Life Sciences Fund III, L.P. TenPercentOwner | 卖出（S） | 56,224 | US$30.05 | US$168.95万 | 8,448,158 | SEC |
| 2026-04-30 2026-04-30 | HTFL Heartflow, Inc. | Bain Capital Life Sciences Investors, LLC TenPercentOwner | 卖出（S） | 56,224 | US$30.05 | US$168.95万 | 8,448,158 | SEC |
| 2026-04-30 2026-04-30 | HTFL Heartflow, Inc. | BCLS Fund III Investments, LP TenPercentOwner | 卖出（S） | 56,224 | US$30.05 | US$168.95万 | 8,448,158 | SEC |
| 2026-04-29 2026-04-30 | HTFL Heartflow, Inc. | Bain Capital Life Sciences III General Partner, LLC TenPercentOwner | 卖出（S） | 797,133 | US$29.37 | US$2341.18万 | 9,396,915 | SEC |
| 2026-04-29 2026-04-30 | HTFL Heartflow, Inc. | BCLS Fund III Investments GP, LLC TenPercentOwner | 卖出（S） | 797,133 | US$29.37 | US$2341.18万 | 9,396,915 | SEC |
| 2026-04-29 2026-04-30 | HTFL Heartflow, Inc. | Bain Capital Life Sciences Fund III, L.P. TenPercentOwner | 卖出（S） | 797,133 | US$29.37 | US$2341.18万 | 9,396,915 | SEC |
| 2026-04-29 2026-04-30 | HTFL Heartflow, Inc. | Bain Capital Life Sciences Investors, LLC TenPercentOwner | 卖出（S） | 797,133 | US$29.37 | US$2341.18万 | 9,396,915 | SEC |
| 2026-04-29 2026-04-30 | HTFL Heartflow, Inc. | BCLS Fund III Investments, LP TenPercentOwner | 卖出（S） | 797,133 | US$29.37 | US$2341.18万 | 9,396,915 | SEC |
| 2026-04-28 2026-04-30 | HTFL Heartflow, Inc. | Bain Capital Life Sciences III General Partner, LLC TenPercentOwner | 卖出（S） | 254,110 | US$30.51 | US$775.29万 | 10,194,048 | SEC |
| 2026-04-28 2026-04-30 | HTFL Heartflow, Inc. | BCLS Fund III Investments GP, LLC TenPercentOwner | 卖出（S） | 254,110 | US$30.51 | US$775.29万 | 10,194,048 | SEC |
| 2026-04-28 2026-04-30 | HTFL Heartflow, Inc. | Bain Capital Life Sciences Fund III, L.P. TenPercentOwner | 卖出（S） | 254,110 | US$30.51 | US$775.29万 | 10,194,048 | SEC |
| 2026-04-28 2026-04-30 | HTFL Heartflow, Inc. | Bain Capital Life Sciences Investors, LLC TenPercentOwner | 卖出（S） | 254,110 | US$30.51 | US$775.29万 | 10,194,048 | SEC |
| 2026-04-28 2026-04-30 | HTFL Heartflow, Inc. | BCLS Fund III Investments, LP TenPercentOwner | 卖出（S） | 254,110 | US$30.51 | US$775.29万 | 10,194,048 | SEC |
| 2026-04-10 2026-04-14 | HTFL Heartflow, Inc. | Farquhar John C.M. Director,Officer · Chief Executive Officer | 卖出（S） | 22,562 | US$26.72 | US$602,856.64 | 549,163 | SEC |
| 2026-04-01 2026-04-03 | HTFL Heartflow, Inc. | Rogers Campbell Officer · Chief Medical Officer | 卖出（S） | 64,533 | US$24.64 | US$159.01万 | 81,002 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| HTFL | 260,159.7918 | 3 | 307,848.4243 | 84.51% | B, Q, N |